Category Archives: Health Care

Dr.Sahar Hashmi, expert in AI in healthcare, Business and Technologies, shares insights at the IHC held in Switzerland in Sep 2023

Dr. Sahar Hashmi, MD-PhDCEO of Myriad Consulting LLC, has expertise in AI in healthcare, digital health, data science, and AI business, with a special emphasis on generative AI applications. 

Dr. Hashmi served as a faculty member at Harvard University, teaching a graduate-level course on “Technology Integrations and Innovations in AI Applications.” This course also discussed the business aspects of AI applications and included predictions about OpenAI’s ChatGPT launch well before it emerged as a competitor to Google search last year in November 2022. 

Dr.Hashmi contributes prominently to the prestigious Entrepreneur magazine in the US on topics related to generative AI applications in enterprises and the roles big tech giants play in healthcare and AI in healthcare generally. https://www.entrepreneur.com/author/sahar-hashmi

Continue reading Dr.Sahar Hashmi, expert in AI in healthcare, Business and Technologies, shares insights at the IHC held in Switzerland in Sep 2023

RAK Hospital Webinar Unlocks the Power of Exercise in Diabetes Management

RAK Hospital Webinar Unlocks the Power of Exercise in Diabetes Management

Exercise is akin to medicine in the treatment of diabetes. 30 minutes of exercise can reduce the risk of diabetes by 40%

Safety precautions and Exercise protocols for Diabetics were explained during the session

Session advised on being vigilant about the warning signs such as extreme fatigue, pain, dizziness, palpitations, fever, chest pain, or irregular heartbeat when performing exercises.

Wearing a diabetes identification bracelet is encouraged to ensure prompt medical attention in case of emergencies.

Continue reading RAK Hospital Webinar Unlocks the Power of Exercise in Diabetes Management

AbbVie to launch epcoritamab in the United Arab Emirates

New hope for non-Hodgkins lymphoma patients AbbVie to launch epcoritamab in the United Arab Emirates

 UAE is the first country after the country of origin (US) to be granted conditional regulatory approval

Dubai, United Arab Emirates, Sep. 12, 2023

TEPKINLY™ (epcoritamab) has received conditional regulatory approval in the United Arab Emirates (UAE) on August 15th 2023, being the first country after the country of origin (United States) to grant conditional regulatory approval. This milestone marks a significant step forward in the field of oncology and offers new hope for patients. TEPKINLY™ (epcoritamab) is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy.

TEPKINLY™ (epcoritamab) is the First and Only Subcutaneous Bispecific Antibody to Treat Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL).6

Continue reading AbbVie to launch epcoritamab in the United Arab Emirates

New Medications and Emerging Therapies are Improving Quality of Life for Individuals with Chronic Migraines

New Medications and Emerging Therapies are Improving Quality of Life for Individuals with Chronic Migraines, says Cleveland Clinic Expert

Development of migraine-specific drugs to prevent and relieve the debilitating condition are proving highly effective, says a headache specialist

September 7, 2023, CLEVELAND: Medications developed over the past few years to treat migraines are significantly improving the quality of life for those with the debilitating condition, according to an expert from global health system Cleveland Clinic.

“Before 2018, when the FDA-approved the first calcitonin gene-related peptide (CGRP) inhibitor to prevent migraines, we had to rely on medications originally designed to treat other diseases, says Emad Estemalik MD, MBA, Section Head for Headache and Facial Pain at Cleveland Clinic’s Neurological Institute. “Today, however, there are several CGRP inhibitors available that have been developed to prevent or to relieve the symptoms of migraines specifically.”

Continue reading New Medications and Emerging Therapies are Improving Quality of Life for Individuals with Chronic Migraines

The Wellbeing Sanctuary offers transformational approach to holistic health and wellness

DecodeYou® program provides pioneering solution to self-mastery through mind training

September 06,2023 , Dubai, UAE: Dubai-based wellness center, The Wellbeing Sanctuary, is pioneering an innovative mind training solution that promotes better mental and physical health by unlocking the subconscious mind. The center’s founder and CEO, Sarmistha Mitra, has introduced the ground-breaking program to help individuals unveil their own pathway to self-mastery, and to build harmonious relationships, establish successful careers, and achieve lasting health and wellness. 

Sarmistha Mitra, founder and CEO, The Wellbeing Sanctuary 

Built upon Sarmistha’s decade of experience as a holistic psychologist, DecodeYou: A Path to Self-Mastery, is a transformational journey that harnesses the power of the subconscious mind to unlock one’s true potential. Exploring the deep well of memories and experiences stored in the subconscious, the program paves the way for participants to prevent and minimize any mental, physical or emotional crises. It comprises five cycles, each centered around a different aspect of self-discovery: coping strategies, duality and balance, karma and peace, rejection and regret, and pain and trauma.

DecodeYou: A Path to Self-Mastery integrates the foundational principles of seven holistic disciplines

Continue reading The Wellbeing Sanctuary offers transformational approach to holistic health and wellness